Multinational healthcare company Johnson & Johnson (NYSE:JNJ) will be reporting results tomorrow before market open. Here’s ...

With recession concerns circulating in the market, Johnson & Johnson (JNJ) stock could stabilize many portfolios. Since its founding in ...

Johnson & Johnson (NYSE: NYSE:JNJ) is set to report its first-quarter earnings on Tuesday, April 15th, before the market ...

We recently published a list of the 11 Best Dividend Paying Stocks According to Hedge Funds. In this article, we are going to ...

Amid fears of broad-brush pharmaceutical tariffs, Jim Cramer defended Johnson & Johnson (NYSE:JNJ) as an unjustified casualty ...

On the positive side, continued growth in sales of key drugs like Darzalex, along with newer products such as Erleada and ...

We recently published a list of Jim Cramer Says Tariff Pain Isn’t Over Yet And Reviews These 9 Stocks. In this article, we ...

US President Donald Trump’s sudden, shocking 90-day pause on his so-called “reciprocal” tariffs (they were not reciprocal) ...

Except it really wasn’t, thanks to the asbestos in that “finest talc obtainable.” According to asbestos.com, in March of this ...

Pharmaceutical stocks tumble as Trump announces imminent “major tariff” on imported drugs. Pfizer, Merck, and Johnson & Johnson shares drop over 4%, dragging the broader S&P 500 lower.

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. This book ...

Johnson & Johnson's Phase 3b APEX study shows Tremfya reduces symptoms and structural damage in psoriatic arthritis patients ...